A polyornithine/carboxymethyl lentinan layer-by-layer self-assembled drug carrier and its preparation method

A layer-by-layer self-assembly, lentinan technology, applied in the direction of drug combination, pharmaceutical formulation, anti-tumor drug, etc., to achieve the effect of wide source, good biological compatibility and simple operation process

Active Publication Date: 2022-05-03
HUAQIAO UNIVERSITY
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the open state of the channel will cause the early burst release of some drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A polyornithine/carboxymethyl lentinan layer-by-layer self-assembled drug carrier and its preparation method
  • A polyornithine/carboxymethyl lentinan layer-by-layer self-assembled drug carrier and its preparation method
  • A polyornithine/carboxymethyl lentinan layer-by-layer self-assembled drug carrier and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1: Preparation of carboxymethyl lentinan

[0044] (1) Dissolve 1g of lentinan in 30mL of isopropanol and stir at room temperature for 6h to dissolve, marked as liquid A;

[0045] (2) Prepare 40 mL of sodium hydroxide solution with a mass fraction of 60%, slowly drop it into solution A, mark it as solution B, and then stir it rapidly for 90 minutes;

[0046] (3) 60 mL of chloroacetic acid with a mass fraction of 60% was added dropwise to the above liquid B within 30 min, and stirred in a water bath at 65° C. for 4 h.

[0047] (4) After the reaction product is cooled, the pH is adjusted to neutral with dilute hydrochloric acid, transferred to a cellulose dialysis bag and purified in distilled water and ultrapure water for 3 days and 4 days respectively;

[0048] (5) The product is rotary evaporated, and then freeze-dried to obtain carboxymethyl lentinan (LC);

[0049] (6) 1604cm appears in the infrared spectrum of carboxymethyl lentinan -1 and 1324cm -1 new...

Embodiment 2

[0050] Embodiment 2: Preparation of MSNs nano core

[0051] (1) Take 48mL of ultrapure water and adjust the pH to 11 to obtain alkaline water, add 100mg of cetyltrimethylammonium bromide (CTAB) into the alkaline water and stir and dissolve in an oil bath at 80°C;

[0052] (2) After CTAB is completely dissolved, slowly drop 500 μL TEOS into the above solution and stir for 2 hours;

[0053](3) After the reaction, the reaction product was first centrifuged at 6000rpm for 2min to remove large particles, and then changed to 12000rpm for 15min to collect MSNs with smaller particles in the supernatant;

[0054] (4) The MSNs obtained above were washed with water and absolute ethanol several times, and the method of acid reflux was used to reflux to remove the template agent CTAB. After each reflux, the MSNs were washed three times with absolute ethanol, and finally the product was ultrasonically dispersed and stored in a dry place. In water ethanol, the MSNs nano core dispersion liqu...

Embodiment 3

[0055] Embodiment 3: Preparation of layer-by-layer self-assembled nanoparticles

[0056] (1) Use PBS of pH 7.4 as a solvent to prepare a polyornithine cationic electrolyte solution with a concentration of 1 mg / mL, and use 0.14 mol / L of sodium chloride as a solvent to prepare a carboxymethyl lentinan anion with a concentration of 1.5 mg / mL a;

[0057] (2) Take the MSNs nano-core dispersion prepared in Example 2 and prepare a suspension with a concentration of 1 mg / mL and drop it into the polyornithine cationic electrolyte solution (the volume ratio of MSNs to polyornithine is 1:1) , collected by centrifugation after stirring;

[0058] (3) Suspend the product obtained in step (2) and drop it into the carboxymethyl lentinan anion electrolyte solution (the volume ratio of MSNs to carboxymethyl lentinan is 1:1.5), and collect by centrifugation after stirring;

[0059] (4) Recycle steps (2) and (3), and finally obtain LbLNPs with one-layer, two-layer, three-layer, and four-layer f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a layer-by-layer self-assembled drug carrier of polyornithine / carboxymethyl lentinan and a preparation method thereof, comprising an MSNs nano core and a layer-by-layer self-assembly of polyornithine and carboxymethyl lentinan in sequence. To form a shell, the MSNs cores were prepared by a sol-gel method. The present invention adopts the combined layer-by-layer self-assembly technology to wrap two polyelectrolytes with potential health-improving properties on the surface of MSNs, which can not only control the burst release effect produced by MSNs, but also obtain a better biological compatibility. release formulation.

Description

technical field [0001] The invention belongs to the technical field of drug carriers, and in particular relates to a polyornithine / carboxymethyl lentinan layer-by-layer self-assembled drug carrier and a preparation method thereof. Background technique [0002] Cervical cancer is the cancer with the fourth highest morbidity and mortality among women in the world. Traditional treatment methods mainly include surgery, radiotherapy and chemotherapy. However, no single strategy for treating cervical cancer is completely effective. For example, traditional chemotherapeutic drugs have poor penetration and no targeting at the tumor site, which determines that the effective drug concentration in the pathological site is low, so there are many side effects. In order to improve the therapeutic effect of chemotherapeutic drugs on cancer, nanotechnology has been developed to develop chemotherapeutic drug delivery carriers. Nano-drug carriers are taken up by tissue cells through osmosis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/34A61K47/36A61K31/704A61P35/00
CPCA61K9/5161A61K9/5146A61K31/704A61P35/00
Inventor 刘源岗王士斌蔡端华龙瑞敏
Owner HUAQIAO UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products